Genetics of stroke

Acta Pharmacologica Sinica

Volumn 31, Issue 9, 2010, Pages 1055-1064

  Guo, Jin Min ^a   Liu, Ai Jun ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

genetics; hemorrhagic stroke; ischemic stroke; stroke

Indexed keywords

ALDOSTERONE; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA GALACTOSIDASE; AMYLOID BETA PROTEIN; ANGIOTENSIN; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; BETA GLOBIN; C REACTIVE PROTEIN; GELATINASE B; GLOBOTRIAOSYLCERAMIDE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LEUKOTRIENE; MATRIX METALLOPROTEINASE; MITOCHONDRIAL DNA; NOTCH3 RECEPTOR; PADGEM PROTEIN; PHOSPHODIESTERASE IV; PLASMINOGEN ACTIVATOR INHIBITOR 1; RENIN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CADASIL; DISEASE COURSE; DNA POLYMORPHISM; ENCEPHALITIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FABRY DISEASE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HEMOSTASIS; HUMAN; HYPERHOMOCYSTEINEMIA; IN VIVO STUDY; LIPID METABOLISM; MELAS SYNDROME; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PROMOTER REGION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SICKLE CELL ANEMIA; SMOOTH MUSCLE FIBER; STROKE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; HUMANS; INTRACRANIAL HEMORRHAGES; STROKE;

EID: 77956385726     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.141     Document Type: Review

References (123)

1. World Health Organization. World Health Statistics 2008. World Health Organization, Geneva. 2008.
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics: 2008 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: E25-46.
3. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 2007; 6: 149-161
4. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): Case control study. Lancet 2004; 364: 953-962
5. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 2006; 37: 1583-1633
6. Brand-Herrmann SM. Where do we go for atherothrombotic disease genetics? Stroke 2008; 39: 1070-1075
7. Degnan JH, Lasky-Su J, Raby BA, Xu M, Molony C, Schadt EE, et al. Genomics and genome-wide association studies: an integrative approach to expression QTL mapping. Genomics 2008: 92; 129-133
8. Schulz UG, Flossmann E, Rothwell PM. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke 2004; 35: 819-824
9. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003; 34: 1364-1369
10. Au KM, Li HL, Sheng B, Chow TC, Chen ML, Lee KC, et al. A novel mutation (C271F) in the Notch3 gene in a Chinese man with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Clin Chim Acta 2007; 376: 229-232
11. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. NOTCH3 mutations in CADASIL, a hereditary adultonset condition causing stroke and dementia. Nature 1996; 383: 707-710
12. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-776
13. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000; 105: 597-605.
14. Lee YC, Yang AH, Liu HC, Wong WJ, Lu YC, Chang MH, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: two novel mutations in the NOTCH3 gene in Chinese. J Neurol Sci 2006; 246: 111-115
15. Santa Y, Uyama E, Chui DH, Arima M, Kotorii S, Takahashi K, et al. Genetic, clinical and pathological studies of CADASIL in Japan:a partial contribution of Notch3 mutations and implications of smooth muscle cell degeneration for the pathogenesis. J Neurol Sci 2003; 212: 79-84.
16. Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, et al. High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 2006; 79: 31-40.
17. LucaA De, Bottillo I, Dasdia MC, Morella A, Lanari V, Bernardini L, et al. Deletions of NF1 gene and exons detected by multiplex ligationdependent probe amplification. J Med Genet 2007; 44: 800-808
18. Driss A, Asare KO, Hibbert JM, Gee BE, Adamkiewicz TV, Stiles JK. Sickle Cell Disease in the Post Genomic Era: a monogenic disease with a polygenic phenotype. Genomics Insights 2009; 2009: 23-48.
19. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 2005; 37: 435-440
20. Nichols FT, Jones AM, Adams RJ. Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing. J Neuroimaging 2001; 11: 354-362
21. Tanji K, Kaufmann P, Naini AB, Lu J, Parsons TC, Wang D, et al. A novel tRNA Val mitochondrial DNA mutation causing MELAS. J Neurol Sci 2008; 270: 23-27
22. Fornuskova D, Brantova O, Tesarova M, Stiburek L, Honzik T, Wenchich L, et al. The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues. Biochim Biophys Acta 2008; 1782: 317-325
23. Rak M, Tetaud E, Godard F, Sagot I, Salin B, Duvezin-Caubet S, et al. Yeast cells lacking the mitochondrial gene encoding the ATP synthase subunit 6 exhibit a selective loss of complex IV and unusual mitochondrial morphology. J Biol Chem 2007; 282: 10853-10864
24. Houstek J, Mracek T, Vojtiskova A, Zeman J. Mitochondrial diseases and ATPase defects of nuclear origin. Biochim Biophys Acta 2004; 1658: 115-121
25. Chou HF, Liang WC, Zhang Q, Goto Y, Jong YJ. Clinical and genetic features in a MELAS child with a 3271T>C mutation. Pediatr Neurol 2008; 38: 143-146
26. Liu AJ, Guo JM, Xia W, Su DF. New strategies for the prevention of stroke. Clin Exp Pharmacol Physiol 2010; 37: 265-271
27. Krupinski J, Turu MM, Martinez-Gonzalez J, Carvajal A, Juan-Babot JO, Iborra E, et al. Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 2006; 37: 1200-1204
28. Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol 2008; 79: 1544-1551
29. Morita A, Nakayama T, Soma M. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens 2006; 19: 593-600.
30. Morita A, Nakayama T, Doba N, Hinohara S, Soma M. Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP concentration and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res 2006; 29: 323-331
31. Liu ZZ , Lv H , Gao F , Liu G, Zheng HG , Zhou YL, et al. Polymorphism in the human C-reactive protein (CRP) gene, serum concentrations of CRP, and the difference between intracranial and extracranial atherosclerosis. Clin Chim Acta 2008; 389: 40-44
32. Tso AR, Merino JG, Warach S. Interleukin-6 174G/C polymorphism and ischemic stroke: a systematic review. Stroke 2007; 38: 3070-3075
33. Pola R, Flex A, Gaetani E, Flore R, Serricchio M, Pola P. Synergistic effect of 174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke 2003; 34: 881-885
34. Greisenegger S, Endler G, Haering D, Schillinger M, Lang W, Lalouschek W, et al. The (174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb Res 2003; 110: 181-186
35. Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 2002; 33: 1420-1423
36. Banerjee I, Gupta V, Ahmed T, Faizaan M, Puneet A, Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: A case-control study in an Indian population. Brain Res Bull 2008; 75: 158-165
37. Chamorro A, Revilla M, Obach V, Vargas M, Planas AM. The -174G/C polymorphism of the interleukin 6 gene is a hallmark of lacunar stroke and not other ischemic stroke phenotypes. Cerebrovasc Dis 2005; 19: 91-95
38. Pereira TV, Rudnicki M, Franco RF, Pereira AC, Krieger JE. Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: a metaanalysis. Am Heart J 2007; 153: 821-830
39. Trompet S, Pons D, DE Craen AJ, Slagboom P, Shepherd J, Blauw GJ, et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci 2007; 1100: 189-198
40. Zee RY, Cheng S, Erlich HA, Lindpaintner K, Rifai N, Buring JE, et al. Intercellular adhesion molecule 1 (ICAM1) Lys56Met and Gly241Arg gene variants, plasma-soluble ICAM1 concentrations, and risk of incident cardiovascular events in 23,014 initially healthy white women. Stroke 2007; 38: 3152-3157
41. Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Boerwinkle E. Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 2007; 195: e76-82.
42. Bis JC, Heckbert SR, Smith NL, Reiner AP, Rice K, Lumley T, et al. Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis 2008; 198: 166-173
43. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor vassociated with resistance to activated protein C. Nature 1994; 369: 64-67
44. Carty CL, Cushman M, Jones D, Lange LA, Hindorff LA, Rice K, et al. Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. Thromb Haemost 2008; 99: 388-395
45. Maguire JM, Thakkinstian A, Sturm J, Levi C, Lincz L, Parsons M, et al. Polymorphisms in platelet glycoprotein 1balpha and factor VII and risk of ischemic stroke: a meta-analysis. Stroke 2008; 39: 1710-1716
46. Slowik A, Dziedzic T, Pera J, Figlewicz DA, Szczudlik A. Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage. Cerebrovasc Dis 2005; 19: 165-170
47. Smith NL, Bis JC, Biagiotti S, Rice K, Lumley T, Kooperberg C, et al. Variation in 24 hemostatic genes and associations with non-fatal myocardial infarction and ischemic stroke. J Thromb Haemost 2008; 6: 45-53.
48. Chen CH, Eng HL, Chang CJ, Tsai TT, Lai ML, Chen HY, et al. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. J Lab Clin Med 2003; 142: 100-105
49. Wiklund P-G, Nilsson L, Ardnor SN, Eriksson P, Johansson L, Stegmayr B, et al. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: Replicated findings in two nested case-control studies based on independent cohorts. Stroke 2005; 36: 1661-1665
50. Attia J, Thakkinstian A, Wang Y, Lincz L, Parsons M, Sturm J, et al. The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis. J Stroke Cerebrovasc Dis 2007; 16: 173-179
51. Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study. J Stroke Cerebrovasc Dis 2007; 16: 153-159
52. Tasdemir N, Tamam Y, Toprak R, Tamam B, Tasdemir MS. Association of apolipoprotein E genotype and cerebrovascular disease risk factors in a Turkish population. Int J Neurosci 2008; 118: 1109-1129
53. Jin ZQ, Fan YS, Ding J, Chen M, Fan W, Zhang GJ, et al. Association of apolipoprotein E 4 polymorphism with cerebral infarction in Chinese Han population. Acta Pharmacol Sin 2004; 25: 352-356
54. Parfenov MG, Nikolaeva TY, Sudomoina MA, Fedorova SA, Guekht AB, Gusev EI, et al. Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity. J Neurol Sci 2007; 255: 42-49
55. Lai CL, Liu CK, Lin RT, Tai CT. Association of apolipoprotein E polymorphism with ischemic stroke subtypes in Taiwan. Kaohsiung J Med Sci 2007; 23: 491-497
56. Debette S, Lambert JC, Garipy J, Fievet N, Tzourio C, Dartigues JF, et al. New insight into the association of apolipoprotein E genetic variants with carotid plaques and intima-media thickness. Stroke 2006; 37: 2917-2923
57. Lemmens R, Görner A, Schrooten M, Thijs V. Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds. Stroke 2007; 38: 1185-1188
58. Giassakis G, Veletza S, Papanas N, Heliopoulos I, Piperidou H. Apolipoprotein E and first-ever ischaemic stroke in Greek hospitalized patients. J Int Med Res 2007; 35: 127-133
59. Kim NS, Kang K, Cha MH, Kang BJ, Moon J, Kang BK, et al. Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans. Biochem Biophys Res Commun 2007; 364: 157-162
60. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 2008; 299: 1265-1276
61. Can Demirdöen B, Türkanolu A, Bek S, Saniso?lu Y, Demirkaya S, Vural O, et al. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Clin Biochem 2008; 41: 1-9.
62. Fortunato G, Rubba P, Panico S, Trono D, Tinto N, Mazzaccara C, et al. A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intimamedia thickness in middle-aged women. Atherosclerosis 2003; 167: 141-148
63. Shin BS, Oh SY, Kim YS, Kim KW. The paraoxonase gene polymorphism in stroke patients and lipid profile. Acta Neurol Scand 2008; 117: 237-243
64. Zintzaras E, Raman G, Kitsios G, Lau J. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 2008; 168: 1077-1089
65. Möllsten A, Stegmayr B, Wiklund PG. Genetic polymorphisms in the renin-angiotensin system confer increased risk of stroke independently of blood pressure: a nested case-control study. J Hypertens 2008; 26: 1367-1372
66. Xu X, Li J, Sheng W, Liu L. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Cerebrovasc Dis 2008; 26: 48-62.
67. Mizuno T, Makino M, Fujiwara Y, Nagura J, Shiga K, Yoshikawa K, et al. Renin-angiotensin system gene polymorphism in Japanese stroke patients. Int Congress Series 2003; 1252: 83-90.
68. Tuncer N, Tuglular S, Kili G, Sazci A, Us O, Kara I. Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke. J Clin Neurosci 2006; 13: 224-227
69. Van Rijn MJ, Bos MJ, Isaacs A, Yazdanpanah M, Arias-Vásquez A, Stricker BH, et al. Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. J Neurol Neurosur Ps 2007; 78: 1083-1087
70. Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 2003; 26: 521-525
71. Kostulas K, Brophy VH, Moraitis K, Manolescu A, Kostulas V, Gretarsdottir S, et al. Genetic profile of ischemic cerebrovascular disease and carotid stenosis. Acta Neurol Scand 2008; 7: 146-152
72. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomization. Lancet 2005; 365: 224-232
73. Kohara K, Fujisawa M, Ando F, Tabara Y, Niino N, Miki T, et al. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study. Stroke 2003; 34 : 1130-1135
74. Kawamoto R, Kohara K, Oka Y, Tomita H, Tabara Y, Miki T. An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and ischemic stroke. J Stroke Cerebrovasc Dis 2005; 14: 67-74.
75. Dikmen M, Ozbabalik D, Gunes HV, Degirmenci I, Bal C, Ozdemir G, et al. Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms. Acta Neurol Scand 2006; 113 : 307-314
76. Fornage M, Mosley TH, Jack CR, de Andrade M, Kardia SL, Boerwinkle E, et al. Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury. Hum Genet 2007; 120: 671-680
77. Humphries SE, Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004; 3: 227-236
78. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-2503
79. Kaplan RC, Smith NL, Zucker S, Heckbert SR, Rice K, Psaty BM. Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. Atherosclerosis 2008; 201: 130-137
80. Armstrong C, Abilleira S, Sitzer M, Markus HS, Bevan S. Polymorphisms in MMP family and TIMP genes and carotid artery intimamedia thickness. Stroke 2007; 38: 2895-2899
81. Houslay MD, Adams DR. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 2003; 370: 1-18.
82. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, Jonsdottir T, et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003; 35: 131-138
83. Bevan S, Porteous L, Sitzer M, Markus HS. Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis. Stroke 2005; 36: 949-953
84. Kostulas K, Gretarsdottir S, Kostulas V, Manolescu A, Helgadottir A, Thorleifsson G, et al. PDE4D and ALOX5AP genetic variants and risk for ischemic cerebrovascular disease in Sweden. J Neurol Sci 2007; 263: 113-117
85. Xue H, Wang H, Song X, Li W, Sun K, Zhang W, et al. Phosphodiesterase 4D gene polymorphism is associated with ischemic and hemorrhagic stroke. Clin Sci (Lond) 2009; 116: 335-340
86. Bevan S, Dichgans M, Wiechmann HE, Gschwendtner A, Meitinger T, Markus HS. Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations. Stroke 2008; 39: 1109-1114
87. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004; 36: 233-239
88. Freiberg JJ, Tybjaerg-Hansen A, Sillesen H, Jensen GB, Nordestgaard BG. Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 2008; 28: 990-996
89. Wang X, Cheng S, Brophy VH, Erlich HA, Mannhalter C, Berger K, et al. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 2009; 40: 683-695
90. Mahabir S, Abnet CC, Qiao YL, Ratnasinghe LD, Dawsey SM, Dong ZW, et al. A prospective study of polymorphisms of DNA repair genes XRCC1, XPD23 and APE/ref-1 and risk of stroke in Linxian, China. J Epidemiol Community Health 2007; 61: 737-741
91. Marciante KD, Totah RA, Heckbert SR, Smith NL, Lemaitre RN, Lumley T, et al. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke. Pharmacogenet Genomics 2008; 18: 535-543
92. Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, Sturm J, et al. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 Polymorphisms on 90-Day Ischemic Stroke Functional Outcome: A Novel Finding. J Stroke Cerebrovasc Dis 2010. doi: 10.1016/j.jstrokecereb rovasdis.2009.10.011
93. Zhang B, Fugleholm K, Day LB, Ye Shu, Weller R, Day Ian NM, et al. Molecular pathogenesis of subarachnoid haemorrhage. Int J Biochem Cell Biol 2003; 35: 1341-1360
94. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, Krestin GP, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008; 70: 1208-1214
95. Levy E, Carman MD, Fernandez-Madrid Y, Power MD, Lieberburg I, Van Duinen SG, et al. Mutation of the Alzheimers disease amyloid gene in hereditary cerebral hemorrhage-Dutch type. Science 1990; 248: 1124-1126
96. Bornebroek M, Haan J, Maat-Schieman MLC, Van Duinen SG, Roos RAC. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I -a review of the clinical, radiologic and genetic aspects. Brain Pathol 1996; 6: 111-114
97. Nishitsuji K, Tomiyama T, Ishibashi K, Kametani F, Ozawa K, Okada R, et al. Cerebral vascular accumulation of Dutch-type Abeta42, but not wild-type Abeta42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type. J Neurosci Res 2007; 85: 2917-2923
98. Maat-Schieman M, Roos R, van Duinen S. Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neuropathology 2005; 25: 288-297
99. Meschia JF, Brott TG, Brown RD. Genetics of cerebrovascular disorders. Mayo Clin Proc 2005; 80: 122-132
100. Revesz T, Holton JL, Lashley T, Plant G, Rostagno A, Ghiso J, et al. Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 2002; 12: 343-357
101. Wei LH, Walker LC, Levy E. Cystatin C. Icelandic-like mutation in an animal model of cerebrovascular beta-amyloidosis. Stroke 1996; 27: 2080-2085
102. Calero M, Pawlik M, Soto C, Castaño EM, Sigurdsson EM, Kumar A, et al. Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. J Neurochem 2001; 77: 628-637
103. Gemmati D, Serino ML, Ongaro A, Tognazzo S, Moratelli S, Resca R, et al. A common mutation in the gene for coagulation factor XIIA( Val 34Leu):A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 2001; 67: 183-188
104. Lim BCB, Ariens RAS, Carter AM, Wesel JM, Grant PJ. Genetic regulation of fibrin structure and function:complex gene-environment interactions may modulate vascular risk. Lancet 2003; 361: 1424-1431
105. Tzourio C, Arima H, Harrap S, Anderson C, Godin O, Woodward M, et al. APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology 2008; 70: 1322-1328
106. Yamada M, Sodeyama N, Itoh Y, Takahashi A, Otomo E, Matsushita M, et al. Association of neprilysin polymorphism with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 2003; 74: 749-751
107. Yamada M. Cerebral amyloid angiopathy and gene polymorphisms. J Neurol Sci 2004; 226: 41-44
108. Obach V, Revilla M, Vila N, Cervera AA, Chamorro AA. alpha(1)- antichymotrypsin polymorphism: a risk factor for hemorrhagic stroke in normotensive subjects. Stroke 2001; 32: 2588-2591
109. Fu Y, Xie R, Wang Y, Chen D, Zhang Y, Wang G, et al. Association between alpha-1-antichymotrypsin gene polymorphism and cerebral hemorrhage. Zhonghua Yi Xue Za Zhi 2002; 82: 915-917 Chinese.
110. Dardiotis E, Hadjigeorgiou GM, Dardioti M, Scarmeas N, Paterakis K, Aggelakis K, et al. Alpha-1 antichymotrypsin gene signal peptide a/t polymorphism and primary intracerebral hemorrhage. Eur Neurol 2008; 59: 307-314
111. Fontanella M, Rainero I, Gallone S, Rubino E, Fenoglio P, Valfr W, et al. Interleukin 6 gene polymorphisms are not associated with aneurysmal subarachnoid haemorrhage in an Italian population. J Neurol Neurosurg Psychiatry 2008; 79: 471-473
112. Strand M, Söderström I, Wiklund PG, Hallmans G, Weinehall L, Söderberg S, et al. Estrogen receptor alpha gene polymorphisms and first-ever intracerebral hemorrhage. Cerebrovasc Dis 2007; 24: 500-508
113. Bos MJ, Schuit SC, Koudstaal PJ, Hofman A, Uitterlinden AG, Breteler MM. Variation in the estrogen receptor alpha gene and risk of stroke: the Rotterdam Study. Stroke 2008; 39: 1324-1326
114. Ko NU, Rajendran P, Kim H, Rutkowski M, Pawlikowska L, Kwok PY, et al. Endothelial nitric oxide synthase polymorphism (-786T->C) and increased risk of angiographic vasospasm after aneurismal subarachnoid hemorrhage. Stroke 2008; 39: 1103-1108
115. Rubattu S, Volpe M, Kreutz R, Ganten U, Ganten D, Lindpaintner K. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet 1996; 13: 429-434
116. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998; 394: 284-287
117. Tward A, Xia YR, Wang X, Shi YS, Park C, Castellani LW, et al. D alcreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 2002; 106: 484-490
118. Rouis M, Adamy C, Duverger N, Lesnik P, Horellou P, Moreau M, et al. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation 1999; 100: 533-540
119. Worrall BB, Degraba TJ. The genetics of cerebrovascular atherosclerosis. J Stroke Cerebrovasc Dis 2002; 11: 220-229
120. Leey JA, McCabe S, Koch JA, Miles TP. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation. Am J Geriatr Pharmacother 2009; 7: 197-203.
121. Blinkenberg EO, Kristoffersen AH, Sandberg S, Steen VM, Houge G. Usefulness of factor V Leiden mutation testing in clinical practice. Eur J Hum Genet 2010; 18: 862-866
122. Dindagur N, Kruthika-Vinod T.P, Christopher R. Thrombophilic gene polymorphisms in puerperal cerebral veno-sinus thrombosis. J Neurol Sci 2006; 249: 25-30.
123. Pruissen DM, Slooter AJ, Rosendaal FR, van der Graaf Y, Algra A. Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke. Blood 2008; 111: 1282-1286